Why a stricter regulation of drugs could foster (not deter) pharmaceutical innovation

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Cylus, Jonathan ORCID: 0000-0001-8269-1578 (2012) Why a stricter regulation of drugs could foster (not deter) pharmaceutical innovation. British Politics and Policy at LSE (21 Sep 2012). Website.

Preview

PDF Download (163kB) | Preview

• Author
• Publisher

Abstract

Huseyin Naci and Jonathan Cylus provide arguments for how to improve the regulation concerning pharmaceutical drugs. Since drugs are not assessed relative to alternatives on the market, they claim it becomes more difficult to accurately evaluate a drug’s successes and harms. Increased innovation and a more streamlined delivery of information are some of the benefits they attribute to more rigorous drug regulations.

Item Type:	Online resource (Website)
Official URL:	http://blogs.lse.ac.uk/politicsandpolicy/
Additional Information:	© 2012 The Authors
Divisions:	Lifecourse, Ageing & Population Health
Subjects:	R Medicine > RA Public aspects of medicine
Date Deposited:	13 Feb 2013 11:47
Last Modified:	11 Dec 2024 12:57
URI:	http://eprints.lse.ac.uk/id/eprint/48619

Actions (login required)

View Item